ESG resolution round-up: Ambiguity around new Swiss law prompts confusion ahead of Novartis AGM

Novartis to put sustainability report up for advisory vote; Exxon lawsuit ‘a governance issue’ but investors remain quiet; Mirova makes third-party assurance demands.